» Articles » PMID: 7761427

Wide Cross-species Aminoacyl-tRNA Synthetase Replacement in Vivo: Yeast Cytoplasmic Alanine Enzyme Replaced by Human Polymyositis Serum Antigen

Overview
Specialty Science
Date 1995 May 23
PMID 7761427
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Because of variations in tRNA sequences in evolution, tRNA synthetases either do not acylate their cognate tRNAs from other organisms or execute misacylations which can be deleterious in vivo. We report here the cloning and primary sequence of a 958-aa Saccharomyces cerevisiae alanyl-tRNA synthetase. The enzyme is a close homologue of the human and Escherichia coli enzymes, particularly in the region of the primary structure needed for aminoacylation of RNA duplex substrates based on alanine tRNA acceptor stems with a G3.U70 base pair. An ala1 disrupted allele demonstrated that the gene is essential and that, therefore, ALA1 encodes an enzyme required for cytoplasmic protein synthesis. Growth of cells harboring the ala1 disrupted allele was restored by a cDNA clone encoding human alanyl-tRNA synthetase, which is a serum antigen for many polymyositis-afflicted individuals. The human enzyme in extracts from rescued yeast was detected with autoimmune antibodies from a polymyositis patient. We conclude that, in spite of substantial differences between human and yeast tRNA sequences in evolution, strong conservation of the G3.U70 system of recognition is sufficient to yield accurate aminoacylation in vivo across wide species distances.

Citing Articles

Transfer RNAs: diversity in form and function.

Berg M, Brandl C RNA Biol. 2020; 18(3):316-339.

PMID: 32900285 PMC: 7954030. DOI: 10.1080/15476286.2020.1809197.


A Yeast-Based Model for Hereditary Motor and Sensory Neuropathies: A Simple System for Complex, Heterogeneous Diseases.

Rzepnikowska W, Kaminska J, Kabzinska D, Binieda K, Kochanski A Int J Mol Sci. 2020; 21(12).

PMID: 32560077 PMC: 7352270. DOI: 10.3390/ijms21124277.


Acceptor Stem Differences Contribute to Species-Specific Use of Yeast and Human tRNA.

Berg M, Genereaux J, Zhu Y, Mian S, Gloor G, Brandl C Genes (Basel). 2018; 9(12).

PMID: 30544642 PMC: 6316282. DOI: 10.3390/genes9120612.


Hypermorphic and hypomorphic AARS alleles in patients with CMT2N expand clinical and molecular heterogeneities.

Weterman M, Kuo M, Kenter S, Gordillo S, Karjosukarso D, Takase R Hum Mol Genet. 2018; 27(23):4036-4050.

PMID: 30124830 PMC: 6240730. DOI: 10.1093/hmg/ddy290.


Role of D-aminoacyl-tRNA deacylase beyond chiral proofreading as a cellular defense against glycine mischarging by AlaRS.

Pawar K, Suma K, Seenivasan A, Kuncha S, Routh S, Kruparani S Elife. 2017; 6.

PMID: 28362257 PMC: 5409826. DOI: 10.7554/eLife.24001.


References
1.
Rose M, Novick P, Thomas J, Botstein D, Fink G . A Saccharomyces cerevisiae genomic plasmid bank based on a centromere-containing shuttle vector. Gene. 1987; 60(2-3):237-43. DOI: 10.1016/0378-1119(87)90232-0. View

2.
Shiba K, Schimmel P, MOTEGI H, Noda T . Human glycyl-tRNA synthetase. Wide divergence of primary structure from bacterial counterpart and species-specific aminoacylation. J Biol Chem. 1994; 269(47):30049-55. View

3.
Hou Y, Schimmel P . A simple structural feature is a major determinant of the identity of a transfer RNA. Nature. 1988; 333(6169):140-5. DOI: 10.1038/333140a0. View

4.
Park S, Schimmel P . Evidence for interaction of an aminoacyl transfer RNA synthetase with a region important for the identity of its cognate transfer RNA. J Biol Chem. 1988; 263(32):16527-30. View

5.
Hill K, Schimmel P . Evidence that the 3' end of a tRNA binds to a site in the adenylate synthesis domain of an aminoacyl-tRNA synthetase. Biochemistry. 1989; 28(6):2577-86. DOI: 10.1021/bi00432a035. View